Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-26
DOI
10.1111/jth.15106
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new paradigm for personalized prophylaxis for patients with severe haemophilia A
- (2020) Xavier Delavenne et al. HAEMOPHILIA
- Current dosing practices for perioperative factor VIII concentrate treatment in mild haemophilia A patients result in FVIII levels above target
- (2019) Lisette M. Schütte et al. HAEMOPHILIA
- Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab
- (2018) Yesim Dargaud et al. HAEMATOLOGICA
- Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq® (human-cl rhFVIII) in previously treated patients with severe haemophilia A
- (2018) Y. Dargaud et al. HAEMOPHILIA
- Prediction of individual factor VIII or IX level for the correction of thrombin generation in haemophilic patients
- (2018) P. Chelle et al. HAEMOPHILIA
- Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab
- (2018) Yesim Dargaud et al. HAEMATOLOGICA
- High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor
- (2018) I. M. Rietveld et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical outcomes in hemophilia A patients undergoing tailoring of prophylaxis based on population-based pharmacokinetic dosing
- (2018) Azusa Nagao et al. THROMBOSIS RESEARCH
- Thrombin generation assay for testing hemostatic effect of factor VIII concentrates in patients with hemophilia A and inhibitors: In vitro results from the PredicTGA study
- (2018) Armando Tripodi et al. THROMBOSIS RESEARCH
- Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH
- (2017) Y. Dargaud et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications
- (2016) H. C. A. M. Hazendonk et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A critical appraisal of one-stage and chromogenic assays of factor VIII activity
- (2016) F. Peyvandi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Haemostatic response to factor VIII administration in patients with haemophilia A measured by thrombin generation and correlation with factor concentrate use
- (2015) G. C. G. Hugenholtz et al. HAEMOPHILIA
- Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction
- (2015) M. V. Ragni et al. HAEMOPHILIA
- Evaluation of Thrombin Generation Assay in Patients With Hemophilia
- (2014) Sezaneh Haghpanah et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- MicroRNAs in hemostasis
- (2014) R. Teruel-Montoya et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays
- (2014) Anna Pavlova et al. THROMBOSIS AND HAEMOSTASIS
- Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives
- (2013) G. Young et al. BLOOD
- Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors
- (2013) H. Luna-Záizar et al. HAEMOPHILIA
- Monitoring rFVIII prophylaxis dosing using global haemostasis assays
- (2013) M. A. AL Hawaj et al. HAEMOPHILIA
- Defining Severity of Hemophilia: More than Factor Levels
- (2013) Anna Pavlova et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis
- (2013) Tomoko Matsumoto et al. THROMBOSIS AND HAEMOSTASIS
- Investigation of the phenotype heterogeneity in severe hemophilia A using thromboelastography, thrombin generation, and thrombodynamics
- (2013) Ivan D. Tarandovskiy et al. THROMBOSIS RESEARCH
- Feasibility of Using Thrombin Generation Assay (TGA) for Monitoring Bypassing Agent Therapy in Patients With Hemophilia Having Inhibitors
- (2012) Yilmaz Ay et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Feasibility of using thrombin generation assay (TGA) for monitoring of haemostasis during supplementation therapy in haemophilic patients without inhibitors
- (2012) Y. Ay et al. HAEMOPHILIA
- Guidelines for the management of hemophilia
- (2012) A. Srivastava et al. HAEMOPHILIA
- Low-titre inhibitors, undetectable by the Nijmegen assay, reduce factor VIII half-life after immune tolerance induction
- (2012) M. DARDIKH et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis
- (2011) Mark van Geffen et al. Hematology
- Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults
- (2011) Mindy L. Simpson et al. THROMBOSIS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now